Related Experiment Video
Updated: Jun 19, 2026

Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana
Published on: April 19, 2014
Expanding the biopharmaceutical industry's involvement in fighting neglected diseases
1Genzyme Corporation in Cambridge, Massachusetts, USA. james.geraghty@genzyme.com
Abstract:
The increasingly recognized need for new products for so-called neglected diseases, which afflict large numbers of people but have received relatively little industry investment, presents a clear example of a "strategic" corporate responsibility. Addressing neglected diseases can be important to "health diplomacy" and other national interests as well. Because industrial capabilities are essential to the development of new drugs and vaccines for these diseases, specific policy initiatives to attract more companies to do such work should also be further developed.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Drug Products: Biologics, Biosimilars and Interchangeables
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Production of Pharmaceuticals
Drug Discovery: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview

